Open original FDA record ↗Recall record
- FDA identifier
- Z-1570-2013
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Jun 25, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Medtronic is providing Healthcare Professionals with important safety information and patient management recommendations regarding the unintended delivery of drug during the priming bolus function for the SynchroMed implantable infusion pump. The unintended delivery of drug can contribute to patient overdose or underdose symptoms which may be clinically relevant.
Source facts
- Action
- Medtronic sent an Urgent Medical Device Correction letter dated May 2013, to all affected customers. The letter described the background and nature of the issue and provided recommendations for patient management and monitoring after initiation of Intrathecal Therapy. The letter directed customers to continue to use the priming bolus precedure; to monitor all patients following start or restart of intrathecal therapy; consider priming the pump prior to implant; and educate caregivers and family members to recognize the signs and sypmtoms associated with intrathecal drug therapy complications. For questions contact your local Medtronic field representative or Medtronic Neuromodulation Technical Services at 1-800-707-0933.
- Initiated
- 2013-06-03
- Root cause
- Device Design
- Terminated
- 2015-05-14
- Distribution
- Worldwide Distribution - USA Nationwide
- Recall number
- Z-1570-2013
- Recall status
- Terminated
- CDRH record ID
- 117981
- FDA classified
- 2013-06-25
- Recall event number
- 65135